Advanced radiotherapy for gynecological cancer patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients with gynecological tumors who have been treated with advanced radiotherapy techniques, including Image Guided Radiotherapy (IGRT), Intensity Modulated Radiotherapy (IMRT), and Stereotactic Body Radiotherapy (SBRT). The study aims to analyze both acute and late toxicity as well as clinical outcomes such as disease-free survival and overall survival. Data will be collected from patients treated at the IRCCS San Raffaele Scientific Institute from January 2005 to January 2024, allowing for a comprehensive evaluation of treatment effects and prognostic factors.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* gynecologic cancer patients
* \>18 years old
* treated with advanced radiotherapy techniques (IGRT, IMRT, SBRT)

Exclusion Criteria:

* other tumors
* \> 90 years old

Where it's running

• San Raffaele Scientific Institute
  Milan, Mi, Italy Recruiting

Study contacts

• Principal investigator: andrei Fodor, MD — IRCCS San Raffaele Scientific Institute
• Study coordinator: Andrei Fodor, MD
• Email: fodor.andrei@hsr.it
• Phone: +390226437634

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Health-Oriented Protocol for Epidermal Radiodermatitis

  This study looks at how skin reactions from radiation therapy affect adults with head/neck or pelvic cancers and whether certain factors influence RID outcomes.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma, RM · NCT07129525

• Comparing total neoadjuvant therapy with surgery for rectal cancer treatment

  This study is testing if rectal cancer patients who respond well to a new treatment can skip surgery and just be monitored to see how they do compared to those who have surgery right away.

  Recruiting Phase 2/3 National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos · Vilnius · NCT06758830

• Optimizing radiotherapy to protect thyroid function in nasopharyngeal carcinoma patients

  This study is testing whether a new way of giving radiotherapy can better protect the thyroid gland in patients with nasopharyngeal cancer compared to the standard treatment.

  Recruiting Phase 3 Jiangxi Provincial Cancer Hospital · Nanchang, Jiangxi · NCT06752239

• Using lithium to prevent cognitive decline after brain radiotherapy in children

  This study is testing if taking lithium can help prevent memory and thinking problems in children who have survived brain tumors and received radiation therapy.

  Recruiting Phase 2 Region Stockholm · Solna, Stockholm County and 1 other locations · NCT06051240

• Comparing two types of radiation therapy for prostate cancer treatment

  This study is testing whether a new type of radiation therapy for prostate cancer works better and is safer than a different method, while also looking at how well the treatment is tolerated by patients.

  Recruiting CHU de Quebec-Universite Laval · Québec · NCT05786742

• Analysis of outcomes and side effects in patients receiving radiation therapy

  This study looks at the results and side effects of radiation therapy in patients at Winterthur Cantonal Hospital to see how treatment can be improved for future patients.

  Recruiting Kantonsspital Winterthur KSW · Winterthur, Canton of Zurich · NCT05192876

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.